First-in-human study evaluating safety, pharmacokinetics, and pharmacodynamics of lorundrostat, a novel and highly selective aldosterone synthase inhibitor
首次人体研究评估了洛伦德司他(一种新型高选择性醛固酮合成酶抑制剂)的安全性、药代动力学和药效学。
期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70000
Shimizu, Hidetoshi; Tortorici, Michael A; Ohta, Yoshiyasu; Ogawa, Kei; Rahman, Sheikh Mohammed Ashfaq; Fujii, Aya; Hiraga, Yuki; Kawai, Mizue; Sugimoto-Kawabata, Kanami; van Iersel, Mattheus Thijs; van Lier, Jan Jaap; Djedjos, Stephen; Slingsby, B T; Rodman, David M